Alessandro Doria

Cardiovascular autonomic neuropathy and risk of kidney function decline in type 1 and type 2 diabetes: findings from the PERL and ACCORD cohorts.

Tang Y, Ang L, Jaiswal M, Dillon BR, Esfandiari NH, Shah HS, Spino C, Plunkett C, Perkins BA, Busui RP, Doria A.

Diabetes. 2023 Jul 19. PMID: 37467433

Rapid kidney function decline and increased risk of heart failure in patients with type 2 diabetes: findings from the ACCORD cohort : Rapid kidney function decline and heart failure in T2D.

Bueno Junior CR, Bano A, Tang Y, Sun X, Abate A, Hall E, Mitri J, Morieri ML, Shah H, Doria A.

Cardiovasc Diabetol. 2023 06 26. 22(1):131. PMID: 37365586

Monogenic diabetes.

Bonnefond A, Unnikrishnan R, Doria A, Vaxillaire M, Kulkarni RN, Mohan V, Trischitta V, Froguel P.

Nat Rev Dis Primers. 2023 03 09. 9(1):12. PMID: 36894549

Variants influencing age at diagnosis of HNF1A-MODY.

Ludwig-Slomczynska AH, Seweryn MT, Radkowski P, Kapusta P, Machlowska J, Pruhova S, Gasperikova D, Bellanne-Chantelot C, Hattersley A, Kandasamy B, Letourneau-Freiberg L, Philipson L, Doria A, Wolkow PP, Malecki MT, Klupa T.

Mol Med. 2022 09 14. 28(1):113. PMID: 36104811

Pharmacogenetics of Cardiovascular Prevention in Diabetes: From Precision Medicine to Identification of Novel Targets.

Morieri ML, Pipino C, Doria A.

J Pers Med. 2022 Aug 29. 12(9). PMID: 36143187

Neuroblastoma suppressor of tumorigenicity 1 is a circulating protein associated with progression to end-stage kidney disease in diabetes.

Kobayashi H, Looker HC, Satake E, D'Addio F, Wilson JM, Saulnier PJ, Md Dom ZI, O'Neil K, Ihara K, Krolewski B, Badger HS, Petrazzuolo A, Corradi D, Galecki A, Wilson PC, Najafian B, Mauer M, Niewczas MA, Doria A, Humphreys BD, Duffin KL, Fiorina P, Nelson RG, Krolewski AS.

Sci Transl Med. 2022 08 10. 14(657):eabj2109. PMID: 35947673

Serum Orotidine: A Novel Biomarker of Increased CVD Risk in Type 2 Diabetes Discovered Through Metabolomics Studies.

Shah HS, Moreno LO, Morieri ML, Tang Y, Mendonca C, Jobe JM, Thacker JB, Mitri J, Monti S, Niewczas MA, Pennathur S, Doria A.

Diabetes Care. 2022 08 01. 45(8):1882-1892. PMID: 35696261

Results of untargeted analysis using the SOMAscan proteomics platform indicates novel associations of circulating proteins with risk of progression to kidney failure in diabetes.

Kobayashi H, Looker HC, Satake E, Saulnier PJ, Md Dom ZI, O'Neil K, Ihara K, Krolewski B, Galecki AT, Niewczas MA, Wilson JM, Doria A, Duffin KL, Nelson RG, Krolewski AS.

Kidney Int. 2022 08. 102(2):370-381. PMID: 35618095

Contribution of rare variants in monogenic diabetes-genes to early-onset type 2 diabetes.

Pezzilli S, Tohidirad M, Biagini T, Scarale MG, Alberico F, Mercuri L, Mannino GC, Garofolo M, Filardi T, Tang Y, Giuffrida F, Mendonca C, Andreozzi F, Baroni MG, Buzzetti R, Cavallo MG, Cossu E, D'Angelo P, De Cosmo S, Lamacchia O, Leonetti F, Morano S, Morviducci L, Penno G, Pozzilli P, Pugliese G, Sesti G, Mazza T, Doria A, Trischitta V, Prudente S.

Diabetes Metab. 2022 09. 48(5):101353. PMID: 35487478

Gain of Function of Malate Dehydrogenase 2 and Familial Hyperglycemia.

Jungtrakoon Thamtarana P, Marucci A, Pannone L, Bonnefond A, Pezzilli S, Biagini T, Buranasupkajorn P, Hastings T, Mendonca C, Marselli L, Di Paola R, Abubakar Z, Mercuri L, Alberico F, Flex E, Ceròn J, Porta-de-la-Riva M, Ludovico O, Carella M, Martinelli S, Marchetti P, Mazza T, Froguel P, Trischitta V, Doria A, Prudente S.

J Clin Endocrinol Metab. 2022 02 17. 107(3):668-684. PMID: 34718610